# Chinese Peptide Company – FDA Inspection, Feb 16, 2012

Source: https://www.keypedia.com/records/fda_inspections/chinese-peptide-company/0f543af3-f995-4f6b-b5cb-1d41df7586ab
Source feed: FDA_Inspections

> FDA inspection 774762 of Chinese Peptide Company, February 16, 2012. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 774762
- Company Name: Chinese Peptide Company
- Inspection Date: 2012-02-16
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1339684 - 2026-09-04](https://www.keypedia.com/records/fda_inspections/chinese-peptide-company/f889fe40-7ad2-48d8-8257-c30bd3168400)
- FDA Inspection 1242852 - 2024-06-14
- [FDA Inspection 967430 - 2016-03-17](https://www.keypedia.com/records/fda_inspections/chinese-peptide-company/1543f4bc-c04a-453f-bcc6-c037c8540263)
- [FDA Inspection 908354 - 2014-11-14](https://www.keypedia.com/records/fda_inspections/chinese-peptide-company/4b9de5c5-c370-4f89-8941-8be2d06a7e24)

Company: https://www.keypedia.com/companies/chinese-peptide-company/ba8c6a32-f679-405b-bb0a-e82713b7cb62

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
